Physician profile
Christopher C Romas
NPI 1417147158
$4,746.93
in general payments reported to CMS, 2019-2025
7 companies · $444 in 2025
The $444 reported for 2025 was more than what 89% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,793 · 2020: $10.35 · 2022: $99.19 · 2023: $283 · 2024: $118 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410 · Travel and Lodging: $334 · Gift: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.03 |
| Travel and Lodging | $334.07 |
| Gift | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $3,498.59 | 2019 | |
| A-Dec, INC. | $728.77 | 2019-2025 | |
| Align Technology, INC. | $414.57 | 2020-2025 | Invisalign, Invisalign First - Comprehensive Phase 2, Itero Element 5d |
| Straumann USA LLC | $52.54 | 2022 | |
| Envista Holdings Corporation | $26.32 | 2024 | Harmonize |
| Elevate Oral Care | $16.09 | 2023 | Just Right 5000, Fluorimax 5000, Advantage Arrest |
| Voco America INC. | $10.05 | 2025 | Futurabond U, Voco Profluorid Varnish, Meron Plus Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Romas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.